| 作者(順位) | 論文題目 | 發表期刊 |
|---|---|---|
| 田宇峯(7) 李健逢(13) |
LAMC2 is a potential prognostic biomarker for cholangiocarcinoma | Oncol Lett. 2023 Oct 30;26(6):533. |
| 田宇峯(6) 李健逢(10) |
Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma | Eur J Med Res. 2023 Dec 15;28(1):593. |
| 田宇峯(6) 李健逢(10) |
Prognostic Significance of DNA Topoisomerase II Alpha (TOP2A) in Cholangiocarcinoma | Front Biosci (Landmark Ed). 2023 Apr 19;28(4):75. |
| 田宇峯(8) | NCAPG deregulation indicates poor patient survival and contributes to colorectal carcinogenesis | Pathol Res Pract. 2023 Jan:241:154238. |
| 田宇峯(7) 李健逢(13) |
Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma | Sci Rep. 2023 Oct 14;13(1):17444. |
| 田宇峯(3) | Incidentally portal vein penetration during cannulation in endoscopic retrograde cholangiopancreatography: a case report | J Surg Case Rep. 2023 Jun 5;2023(6):rjad298. |
| 田宇峯(6) | Punicalagin is cytotoxic to human colon cancer cells by modulating cell proliferation, apoptosis, and invasion | Hum Exp Toxicol. 2023 Jan-Dec:42:9603271231213979. |
| 田宇峯(5) | Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarke | Diagnostics (Basel). 2023 Jul 6;13(13):2296. |
| 李健逢(5) | Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer | Int J Biol Macromol. 2023 Aug 1:245:125510. |
| 李宛珊(9) 李健逢(C) |
A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases | Mod Pathol. 2023 Sep;36(9):100242. |
| 李健逢(2) | Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab | Front Immunol. 2023 Mar 27:14:1131448. |
| 李健逢(1) | PAK1 overexpression promotes myxofibrosarcoma angiogenesis through STAT5B-mediated CSF2 transactivation: clinical and therapeutic relevance of amplification and nuclear entry | Int J Biol Sci. 2023 Jul 31;19(12):3920-3936. |
| 李健逢(9) | Deep-learning based breast cancer detection for cross-staining histopathology images | Heliyon. 2023 Jan 21;9(2):e13171. |
| 李健逢(4) | Downregulation of CRTAC1 in Urothelial Carcinoma Promotes Tumor Aggressiveness and Confers Poor Prognosis | Front Biosci (Landmark Ed). 2023 Sep 24;28(9):217. |
| 李健逢(4) | Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs | Sci Rep. 2023 Mar 9;13(1):3943. |
| 李宛珊(8) 李健逢(C) |
Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder | World J Surg Oncol. 2023 Feb 25;21(1):62. |
| 李健逢(5) | Early Postoperative Outcomes of Retroperitoneal Partial Nephrectomy of Anterior and Posterior Renal Tumors: A 5-Year Experience in A Single Center | J Endourol. 2023 May;37(5):557-563. |
| 李健逢(10) | The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma | Cell Oncol (Dordr). 2023 Aug;46(4):933-951. |
| 李宛珊(17) | Extraskeletal Myxoid Chondrosarcomas: The Uncommon Clinicopathologic Manifestations and Significance of TAF15::NR4A3 Fusion | Mod Pathol. 2023 Jul;36(7):100161. |